PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

FDA Approves a New Generic Valsartan to Mitigate Shortages

by PEPID Newsroom | Mar 14, 2019 | Alerts

As of March 12, 2019 the U.S. FDA approved a new generic of Diovan (valsartan) for high blood pressure and heart failure to relieve the shortage from multiple recalls of generic valsartan products from several manufacturers. The approval of the new generic of Diovan...

Recent Posts

  • Dementia in the Emergency Department: Recognizing Delirium, Anticholinergic Burden, and the “Acting Different” Presentation
  • Heat-Related Illness in the Emergency Department: Recognition, Cooling, and the High-Risk Patient
  • EMS Week in Practice: Strengthening the Prehospital-to-ED Continuum for Better Patient Outcomes
  • Sleep Awareness Week: Why Sleep Health Should Be Part of Every Wellness Visit
  • Autism Acceptance Month: Autism in Clinical Practice—Communication Strategies and Considerations for Better Care

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved